Skip to Content
Merck

Wnt3a Facilitates SARS-CoV-2 Pseudovirus Entry into Cells.

International journal of molecular sciences (2024-01-11)
Ivonne Melano, Hui-Jye Chen, Loveness Ngwira, Pang-Hung Hsu, Li-Lan Kuo, Lloyd Noriega, Wen-Chi Su
ABSTRACT

How ACE2 functions as the major host receptor of SARS-CoV-2 despite having low expression in the lungs is still unknown. To facilitate the development of therapeutic strategies against coronaviruses, gaining a deeper comprehension of the molecular mechanism of SARS-CoV-2 infection is imperative. In our previous study, we identified several potential host factors of SARS-CoV-2 using an shRNA arrayed screen, one of which was Wnt3a. Here, we validated the significance of Wnt3a, a potent activator of the Wnt/β-catenin signaling pathway, for SARS-CoV-2 entry into cells by evaluating the effects of its knockdown and overexpression on SARS-CoV-2 pseudotyped virus entry. Further analysis revealed that SARS-CoV-2 pseudotyped virus infection activates the canonical Wnt/β-catenin signaling pathway, which we found could subsequently stimulate ACE2 transcription. Collectively, our study identified Wnt3a as an important host factor that facilitates ACE2-mediated virus infection. Insight into the virus entry mechanism is impactful as it will aid in developing novel therapeutic strategies against current and future coronavirus pandemics.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-HA Tag Antibody, clone DW2, rabbit monoclonal, culture supernatant, clone DW2, from rabbit